细胞助手

Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immunethrombocytopenia: a prospective, single arm, phase I trial

, ,


发表回复

免责声明:本网站目的在于科普相关知识传播,非盈利性质,全部资料均来源于网络,如有侵权请联系删除!